Steffen Sammet to Treatment Outcome
This is a "connection" page, showing publications Steffen Sammet has written about Treatment Outcome.
Connection Strength
0.044
-
Validation of optimal DCE-MRI perfusion threshold to classify at-risk tumor imaging voxels in heterogeneous cervical cancer for outcome prediction. Magn Reson Imaging. 2014 Dec; 32(10):1198-205.
Score: 0.013
-
Microcirculatory fraction (MCF(I)) as a potential imaging marker for tumor heterogeneity in breast cancer. Magn Reson Imaging. 2012 Oct; 30(8):1059-67.
Score: 0.011
-
Characterizing tumor heterogeneity with functional imaging and quantifying high-risk tumor volume for early prediction of treatment outcome: cervical cancer as a model. Int J Radiat Oncol Biol Phys. 2012 Jul 01; 83(3):972-9.
Score: 0.011
-
Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer. J Clin Oncol. 2010 May 10; 28(14):2323-30.
Score: 0.009